Literature DB >> 35293784

Bionized Nanoferrite Particles Alter the Course of Experimental Cryptococcus neoformans Pneumonia.

Livia C Liporagi Lopes1,2, Preethi Korangath3, Robert Ivkov3,4,5,6, Samuel R Dos Santos1,7, Kathleen L Gabrielson8,9,4, Arturo Casadevall1.   

Abstract

Cryptococcosis is a devastating fungal disease associated with high morbidity and mortality even when treated with antifungal drugs. Bionized nanoferrite (BNF) nanoparticles are powerful immunomodulators, but their efficacy for infectious diseases has not been investigated. Administration of BNF nanoparticles to mice with experimental cryptococcal pneumonia altered the outcome of infection in a dose response manner as measured by CFU and survival. The protective effects were higher at lower doses, with reductions in IL-2, IL-4, and TNF-α, consistent with immune modulation whereby reductions in inflammation translate into reduced host damage, clearance of infection, and longer survival.

Entities:  

Keywords:  cryptococcal pneumonia; immune system; iron oxide nanoparticles

Mesh:

Substances:

Year:  2022        PMID: 35293784      PMCID: PMC9017294          DOI: 10.1128/aac.02399-21

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.938


  41 in total

Review 1.  Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance.

Authors:  M A Ghannoum; L B Rice
Journal:  Clin Microbiol Rev       Date:  1999-10       Impact factor: 26.132

Review 2.  Nanovaccines : nanocarriers for antigen delivery.

Authors:  Jose Vicente Gonzalez-Aramundiz; Ana Sara Cordeiro; Nœmi Csaba; Maria de la Fuente; María José Alonso
Journal:  Biol Aujourdhui       Date:  2013-02-19

Review 3.  Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis.

Authors:  Kyung J Kwon-Chung; James A Fraser; Tamara L Doering; Zhou Wang; Guilhem Janbon; Alexander Idnurm; Yong-Sun Bahn
Journal:  Cold Spring Harb Perspect Med       Date:  2014-07-01       Impact factor: 6.915

4.  Serologic evidence for Cryptococcus neoformans infection in early childhood.

Authors:  D L Goldman; H Khine; J Abadi; D J Lindenberg; R Niang; A Casadevall
Journal:  Pediatrics       Date:  2001-05       Impact factor: 7.124

5.  Microevolution of a standard strain of Cryptococcus neoformans resulting in differences in virulence and other phenotypes.

Authors:  S P Franzot; J Mukherjee; R Cherniak; L C Chen; J S Hamdan; A Casadevall
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

Review 6.  Progress in antiretroviral drug delivery using nanotechnology.

Authors:  Rama Mallipeddi; Lisa Cencia Rohan
Journal:  Int J Nanomedicine       Date:  2010-08-09

Review 7.  Magnetic Nanoparticles in Cancer Theranostics.

Authors:  Oliviero L Gobbo; Kristine Sjaastad; Marek W Radomski; Yuri Volkov; Adriele Prina-Mello
Journal:  Theranostics       Date:  2015-09-01       Impact factor: 11.556

8.  The metal nanoparticle-induced inflammatory response is regulated by SIRT1 through NF-κB deacetylation in aseptic loosening.

Authors:  Zhantao Deng; Jiewen Jin; Zhenheng Wang; Yong Wang; Qian Gao; Jianning Zhao
Journal:  Int J Nanomedicine       Date:  2017-05-10

Review 9.  Fighting the Monster: Applying the Host Damage Framework to Human Central Nervous System Infections.

Authors:  Anil A Panackal; Kim C Williamson; Diederik van de Beek; David R Boulware; Peter R Williamson
Journal:  MBio       Date:  2016-01-26       Impact factor: 7.867

10.  Nanoparticle interactions with immune cells dominate tumor retention and induce T cell-mediated tumor suppression in models of breast cancer.

Authors:  Preethi Korangath; James D Barnett; Anirudh Sharma; Elizabeth T Henderson; Jacqueline Stewart; Shu-Han Yu; Sri Kamal Kandala; Chun-Ting Yang; Julia S Caserto; Mohammad Hedayati; Todd D Armstrong; Elizabeth Jaffee; Cordula Gruettner; Xian C Zhou; Wei Fu; Chen Hu; Saraswati Sukumar; Brian W Simons; Robert Ivkov
Journal:  Sci Adv       Date:  2020-03-25       Impact factor: 14.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.